Researcher
Els Van Valckenborgh
- Keywords:Medicine
Affiliations
- Faculty of Medicine and Pharmacy (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2018 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2017 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 30 Sep 2017 - Immunology and Microbiology (Department)
Member
From1 Feb 2012 → 31 Dec 2013 - Hematology (Research group)
Member
From1 Oct 2000 → 31 Dec 2014 - Immunology and Microbiology (Department)
Member
From1 Aug 2000 → 31 Dec 2013
Projects
1 - 5 of 5
- A study to target tumor-associated macrophages in multiple myeloma.From1 Jan 2016 → 31 Dec 2016Funding: FWO research grant KAN
- Drug resistance in multiple myeloma: study of extrinsic mechanisms governed by the bone marrow microenvironmentFrom1 Jan 2014 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Study of resistance mechanisms in multiple myelomaFrom1 Jan 2013 → 31 Dec 2013Funding: FWO research grant KAN
- The interest of aldehyde dehydrogenase positive cells in the evolution of multiple myelomaFrom1 Jan 2011 → 31 Dec 2011Funding: FWO research grant KAN
- Identification and characterisation of the cancer stem cell in multiple myelomaFrom1 Jan 2009 → 31 Dec 2009Funding: FWO research grant KAN
Publications
21 - 30 of 75
- Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model(2014)
Authors: Haneen Nur, Luigia Rao, Ma Frassanito, D. Ribatti, Josue Mfopou Kunjom, E Van Valckenborgh, Angelo Vacca
Pages: 651-663 - Cancer associated fibroblasts and tumor growth: focus on multiple myeloma.(2014)
Authors: Luigia Rao, E Van Valckenborgh, Ma Frassanito, L. Di Marzo, Angelo Vacca
Pages: 1363-1381 - Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells(2014)
Authors: Jinheng Wang, An Hendrix, Miguel Lemaire, E Van Valckenborgh, Olivier De Wever
Pages: 555-566 - The IGF-1 receptor inhibitor picropodophyllin potentiates the
anti-myeloma activity of a BH3-mimetic.(2014)
Authors: Liesbeth Bieghs, Susanne Lub, Karel Fostier, E Van Valckenborgh, He Johnsen, Mette Nyegaard, H Jernberg-Wiklund
Pages: 11193-11208 - The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.(2014)
Authors: Miguel Lemaire, Els Van Valckenborgh, Steve Mcclue
Pages: 3115-3129 - Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies(2014)
Authors: Miguel Lemaire, E Van Valckenborgh, Peter Kronenberger, U. Wernery
Pages: 444-447 - Activation of invariant natural killer T cells reduces angiogenesis in the 5T33 multiple myeloma model(2014)
Authors: Haneen Nur, Luigia Rao, Angelo Vacca, Dirk Elewaut, E Van Valckenborgh
Pages: 24-25 - Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro.(2013)
Authors: Jinsong Hu, E Van Valckenborgh, Dehui Xu, Song Xu, Benjamin Van Camp, Damian R Handisides, Charles Hart
Pages: 1763-1773 - Preclinical evaluation of invariant natural killer T cells in the 5T33 multiple myeloma model(2013)
Authors: Haneen Nur, Karel Fostier, Sandrine Aspeslagh, Wim Renmans, Elisabeth Bertrand, Xavier Leleu, Mérédis Favreau, Karine Breckpot, Henri Schots, Marc De Waele, et al.
- Epigenetic regulation of myeloma within its bone marrow microenvironment(2013)Volume: 1
Authors: Elke De Bruyne, Ken Maes, Sarah Deleu, E Van Valckenborgh, Eline Menu, Isabelle Vande Broek, Joanna Fraczek, Leo A van Grunsven, Vera Rogiers, Helena Jernberg-Wiklund, et al.
Pages: 255-282Number of pages: 28